Black Rock Inc. Aim Immuno Tech Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Aim Immuno Tech Inc. stock. As of the latest transaction made, Black Rock Inc. holds 698,267 shares of AIM stock, worth $160,601. This represents 0.0% of its overall portfolio holdings.
Number of Shares
698,267
Previous 698,333
0.01%
Holding current value
$160,601
Previous $328,000
21.34%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AIM
# of Institutions
36Shares Held
9.01MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY4.33MShares$995,9000.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.99MShares$457,4010.0% of portfolio
-
Geode Capital Management, LLC Boston, MA464KShares$106,7230.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il458KShares$105,2860.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny243KShares$55,9370.0% of portfolio
About AIM ImmunoTech Inc.
- Ticker AIM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,049,300
- Market Cap $11.1M
- Description
- AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...